Center for Experimental Therapeutics and Reperfusion Injury, Department of Anesthesiology, Perioperative, and Pain Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA.
Section on Integrative Physiology and Metabolism, Research Division, Joslin Diabetes Center and Harvard Medical School, Boston, MA 02215, USA.
J Clin Endocrinol Metab. 2024 Jun 17;109(7):1837-1849. doi: 10.1210/clinem/dgae016.
Activation of brown adipose tissue (BAT) thermogenesis improves insulin sensitivity and is beneficial in obesity. Emerging evidence indicates that BAT activation increases lipid mediators that play autocrine and endocrine roles to regulate metabolism and inflammation.
The goal of the study was to determine the relationship between 2 distinct approaches of BAT activation (cold exposure and mirabegron treatment) with lipid mediators in humans.
Healthy female subjects (n = 14) were treated with the β3-adrenergic receptor agonist mirabegron (100 mg) daily for 28 days. A subset of female subjects (n = 8) was additionally exposed to cold temperatures (14-16 °C) for 2 hours using a cooling vest prior to initiating mirabegron treatment. A panel of lipid mediators was assessed in plasma using targeted liquid chromatography-tandem mass spectrometry, and their relationship to anthropometric and metabolic parameters was determined.
Activation of BAT with cold exposure acutely increased levels of lipoxygenase and cyclooxygenase products, including 12-hydroxyeicosapentaenoic acid, 12-hydroxyeicosatetraenoic acid (HETE), 5-HETE, 14-hydroxydocosahexaenoic acid (HDHA), an isomer of maresin 2 (MaR2), 17-HDHA, protectin D1 (PD1), and prostaglandin E2. Mirabegron treatment similarly increased these products acutely, although levels of some mediators were blunted after chronic mirabegron treatment. Selected lipid mediators, including an MaR2 isomer, 17-HDHA, 5-HETE, and 15-HETE, positively correlated with nonesterified fatty acids and negatively correlated with the respiratory quotient, while PD1, 15-HETE, and 5-HETE positively correlated with adiponectin.
These results indicate that selected lipid mediators may serve as biomarkers of BAT activation.
棕色脂肪组织(BAT)的激活可改善胰岛素敏感性,并有益于肥胖症。新出现的证据表明,BAT 的激活会增加脂质介质,这些介质发挥自分泌和内分泌作用,以调节代谢和炎症。
本研究旨在确定两种不同的 BAT 激活方法(冷暴露和米拉贝隆治疗)与人类脂质介质之间的关系。
健康女性受试者(n=14)每天接受β3-肾上腺素能受体激动剂米拉贝隆(100mg)治疗 28 天。一部分女性受试者(n=8)在开始米拉贝隆治疗前,使用冷却背心将体温降低至 14-16°C 2 小时,以激活 BAT。使用靶向液相色谱-串联质谱法检测血浆中的脂质介质谱,并确定其与人体测量和代谢参数的关系。
冷暴露激活 BAT 可使脂氧合酶和环氧化酶产物水平急性增加,包括 12-羟基二十碳五烯酸、12-羟基二十碳四烯酸(HETE)、5-HETE、14-羟基二十二碳六烯酸(HDHA)、maresin 2(MaR2)的一种异构体、17-HDHA、保护素 D1(PD1)和前列腺素 E2。米拉贝隆治疗同样可使这些产物急性增加,但慢性米拉贝隆治疗后,某些介质的水平会减弱。一些选定的脂质介质,包括 MaR2 异构体、17-HDHA、5-HETE 和 15-HETE,与非酯化脂肪酸呈正相关,与呼吸商呈负相关,而 PD1、15-HETE 和 5-HETE 与脂联素呈正相关。
这些结果表明,一些选定的脂质介质可能作为 BAT 激活的生物标志物。